Application no. and date | 05744537.1 (espacenet) (Federated) (European Patent Register), 20050503 | Patent/reg. no. and date | DK/EP 1755596, 20150812 | Publication date | 20070228 | Priority no. and date | US 568043 P, 20040504, US 607533 P, 20040907, US 119558, 20050502 | EP pub. no. and date |
EP 1755596 20070228 | Effective date | | Applicant/owner | Bristol-Myers Squibb Holdings Ireland Unlimited Company, Hinterbergstrasse 16
6312 Steinhausen, CH | Applicant ref. no. | V134719 B9 | Inventor | SRIVASTAVA, Sushil, K., 9 Kayann Drive
Dayton, NJ 08810, US, GOUGOUTAS, Jack, Z., 101 Westerly Road
Princeton, NJ 08540, US, DAVIDOVICH, Martha, 159 Fern Road
East Brunswick, NJ 08816, US, LOTZ, Bruce, T., 16 Windsor Lane
Yardville, NJ 08620, US, MALLEY, Mary, F., 50 Merion Place
Lawrenceville, NJ 08648, US, KIM, Soojin, 23 Country Club Way
Demarest, NJ 07627, US | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | Opponent | | IPC Class | A61K 31/44 (2006.01) , C07D 213/56 (2006.01) | Title | FREMGANGSMÅDE TIL FREMSTILLING AF ATAZANAVIRBISULFAT OG HIDTIL UKENDTE
FORMER | Int. application no. | US2005015333 | Int. publication no. | WO2005108349 | Related patent (certificate) | | Status | Rettet DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|